Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 11 , Pages 879-884 , November 2011

Dietary phosphate restriction in dialysis patients: A new approach for the treatment of hyperphosphataemia

  • B. Guida

      Affiliations

    • Department of Neuroscience, Physiology Nutrition Unit, University Federico II, Naples, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 081 7463216; fax: +39 081 7463639.
    • ,
  • A. Piccoli

      Affiliations

    • Department of Medical and Surgical Sciences, University of Padova, Italy
    • ,
  • R. Trio

      Affiliations

    • Department of Neuroscience, Physiology Nutrition Unit, University Federico II, Naples, Italy
    • ,
  • R. Laccetti

      Affiliations

    • Department of Neuroscience, Physiology Nutrition Unit, University Federico II, Naples, Italy
    • ,
  • A. Nastasi

      Affiliations

    • Department of Neuroscience, Physiology Nutrition Unit, University Federico II, Naples, Italy
    • ,
  • A. Paglione

      Affiliations

    • Department of Neuroscience, Physiology Nutrition Unit, University Federico II, Naples, Italy
    • ,
  • A. Memoli

      Affiliations

    • Division of Nephrology, University Federico II, Naples, Italy
    • ,
  • B. Memoli

      Affiliations

    • Division of Nephrology, University Federico II, Naples, Italy

Received 12 November 2009 ,Revised 28 January 2010 ,Accepted 10 February 2010.

References 

  1. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphate and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607–617
  2. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  3. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771–780
  4. Cupisti A, Morelli E, D'Alessandro C, Lupetti S, Barsotti G. Phosphate control in chronic uremia: don't forget diet. J Nephrol. 2003;16(1):29–33
  5. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis. 2000;35(6):1226–1237
  6. Cannata-Andia JB, Rodriguez-Garcia M. Hyperphosphatemia as a cardiovascular risk factor—how to manage the problem. Nephrol Dial Transplant. 2002;11(Suppl. 17):16–19
  7. Boaz M, Smetana S. Regression equation predicts dietary phosphate intake from estimate of dietary protein intake. J Am Diet Assoc. 1996;96(12):1268–1270
  8. Locatelli F, Cannata-Andía JB, Drüeke TB, Hörl WH, Fouque D, Heimburger O, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphatemia. Nephrol Dial Transplant. 2002;17(5):723–731
  9. Rufino M, de Bonis E, Martin M, Rebollo S, Martin B, Miquel R, et al. It is possible to control hyperphosphataemia with diet, without inducing protein malnutrition?. Nephrol Dial Transplant. 1998;13(Suppl. 3):65–67
  10. Al Aly Z, Gonzalez EA, Martin KJ, Gellens ME. Achieving K/DOQI laboratory target values for bone and mineral metabolism: an uphill battle. Am J Nephrol. 2004;24(4):422–426
  11. Hu FB, Rimm E, Smith-Warner SA, Feskanich D, Stampfer MJ, Ascherio A, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr. 1999;69(2):243–249
  12. Daugirdas JT. Second generation logarithmic estimates of single pool variable volume Kt = V: an analysis of error. J Am Soc Nephrol. 1993;4:120–213
  13. Strain GW, Zumoff B. The relationship of weight–height indices of obesity to body fat content. J Am Coll Nutr. 1992;11(6):715–718
  14. Piccoli A, Rossi B, Pillon L, Bucciante G. A new method for monitoring body fluid variation by bioimpedance analysis: the RXc graph. Kidney Int. 1994;46:534–539
  15. Kotler DP, Burastero S, Wang J, Pierson RN. Prediction of body cell mass, fat-free mass and total body water with bioelectrical impedance analysis: effect of race, sex, and disease. Am J Clin Nutr. 1996;64(3):489–497
  16. Kushner RF, Kunigk A, Alspaugh M, Andronis PT, Leitch CA, Schoeller DA. Validation of bioelectrical-impedance analysis as a measurement of change in body composition in obesity. Am J Clin Nutr. 1990;52(2):219–223
  17. Schoenfeld P, Henry R, Laird N, Roxe D. Assessment of nutritional status of the National Cooperative Dialysis Study population. Kidney Int. 1983;13:S80–S88
  18. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, et al. Is controlling phosphate by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?. Am J Clin Nutr. 2008;88(6):1511–1518
  19. Ramirez A, Emmett M, White MG, Fahti N, Santa Ana CA, Morawski SG, et al. The absorption of dietary phosphate and calcium in hemodialysis patients. Kidney Int. 1986;30:753–759
  20. Delmez J, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal failure. Am J Kidney Dis. 1992;19:303–317
  21. Morton AR, Hercz D, Coburn JW. Control of hyperphosphatemia in chronic renal failure. Semin Dial. 1990;3:219–223
  22. Sheik MS, Maguire JA, Emmet M, Santa Ana CA, Nicar MJ, Schiller LR. Reduction of phosphate diet absorption by phosphate binder. A theoretical, in vitro and in vivo study. J Clin Invest. 1989;83(1):66–73
  23. Mai ML, Emmett M, Sheikh MS, Santa Ana CA, Schiller L, Fordtran JS. Calcium acetate, an effective phosphate binder in patients with renal failure. Kidney Int. 1989;36(4):690–695
  24. Sherman RA, Mehta O. Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol. 2009;4(8):1370–1373
  25. Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease. JAMA. 2009;301(6):629–635
  26. Drueke T. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int. 1995;48(1):259–272
  27. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2:999–1007

PII: S0939-4753(10)00070-0

doi: 10.1016/j.numecd.2010.02.021

Nutrition, Metabolism & Cardiovascular Diseases
Volume 21, Issue 11 , Pages 879-884 , November 2011

Article Tools

* Image Usage & Resolution